MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree, accurate interpretation of financials are important. MYDX is improving and strengthening and is showing no signs of slowing down, which translates nicely to investors who are taking an OTC risk.
Financials specs LACK vision. Those things currently don't matter to investors. Investors have vision and they know where MYDX is headed.
A lot of serious investors who don't normally seek out OTC but see and hear about MYDX and do all the necessary DD and agree that investing in MYDX is a no-brainer GO but their brokerage doesn't trade subpenny are ALL waiting for .01 and when that happens, because of how long the sp has been subpenny will skyrocket buyer urgency at .01 and we will see 100s possibly even 1,000s of millions of shares fighting for the best position and that is why investors are saying .10 by end of 2017 and .25 by this time 2018. MYDX is a no-brainer GO after ALL DD. MYDX is the PREMIER HOUSEHOLD CANNABIS PRODUCT. Where's the competition. What other company is acquiring the data MYDX is? You can't do that without an accessible product.
The longer MYDX sits subpenny, the more time to accumulate investors sitting at .01with thousands of dollars to buy in. All that adds up to expectations.
Ha! Selloff? Same shares keep trading same hands trying to take MYDX down. Along the way investors are accumulating and will drive price way high with demand. It's only a matter of time. Soon will be the days of 100s of millions not 10s of millions. MYDX is a serious player in the OTC. It won't stay this low for long. Urgency will kick in and its back to multipennies.
Progress is in the works, vision isn't seeing what is, it's EVERYTHING affected by many factors. Sp will be great for investors ROI. No selling 2017.
Investors have vision. Financials will progress with the growth of MYDX. Investors are not selling 2017 and will continue to accumulate shares.
The real DD is available for all to see.
The countdown to urgency started this morning and will continue through the weekend. Sp should be able to close +15% for the day without hype or news, all the DD really has been done and is available for all to see. Real references, not speculation based on ideas.
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
https://www.google.com/amp/s/amp.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona Why would Big Pharma want to stop something they don't care to get into?
Yep, it's all about cannabis research and research is in Canada and Canada is ahead of US in cannabis research and MYDX is laying a solid foundation in the country that is the forefront of all the research. Great strategy by MYDX:
https://www.leafly.com/news/science-tech/medical-marijuana-research-from-canadian-producers
Of course, US is also researching cannabis but who knows when it will create policy for legalization.
MYDX is taking all the risk because large corporations can just buy their way in:
https://www.google.com/amp/s/www.greenrushdaily.com/apple-not-developing-ivape-vaporizer/amp/
Looks like this tech giant will be billions away and years behind MYDX like other tech giants who don't want to risk what MYDX is already in the process of doing and has already accomplished by creating a company that is selling cannabis related products and becoming cash flow positive. This company will continue to update the public on topics that are important for people to know, for people who want to live a better life. MYDX is the solution and other companies will have to go through MYDX.
How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already?
How many big pharma companies are developing a medicinal marijuana vape pen that communicates to a device that can be used by doctors to help aid in prescribing remedies for their patients? Is it because they already know MYDX is doing it and is planning on releasing the product to the market by end of year? Are big pharma not taking the risk because they know they can just buy their way into MYDX and go through MYDX? How will all this affect current shareholders?
This topic has already been around a good while and will only intensify as countdown progresses to Canadian legalization and MYDX having a foothold in Canada will be a seamless entry into US households not to mention it has continued building an investment shareholder presence which is rare in OTC:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
That's all about to change in favor of MYDX and future customers.
A lot of toxic financiers hired by private special interest companies who are hired by companies that are threatened by MYDX's success will be out of a job as sp continues to increase on the regular.
Yep straight down to 10% interesting eh? Shorters good luck keeping it down. MYDX is already strengthened by investors.
MYDX is MYDX, no hype necessary.
Consumer confidence will only grow with testimonies from actual product users, good or bad. Consumer confidence, good or bad, is what really matters to someone considering to buy a product. It's a very curious product. Anyone wanting to satisfy their curiosity will have to buy the product. More consumers than not, I believe will be verifying that the product works the way it's supposed to work.
That's for the consumer who bought the product to determine.
How can they be reliable when all they are saying is a product doesn't work because it's junk. And someone who has used it explains how it worked for them. Which is verified? It depends on the next person. The point being, the product has to be bought before it can be verified.
Most testimonials in general are real, of course ALL speculators are NOT verified as reliable. So it is important as consumers to do your own DD before buying any product, not only by what others say.
Why market in Canada and US when Canada is drawing up policy to take effect in a year. US is already aware of what Canada is doing. MYDX is getting both for the price of ONE, BRILLIANT!!
I trust testimonies of consumers who have bought and used the device on a regular basis and I do not trust speculators who do not own the product or use on a regular basis that claim the product is junk.
I was simply stating a FACT and that is, the higher MYDX closes green, the higher the lows for shorters given they are only legally able to drop the price 10% from previous close.
I like that shout out to supporting shareholders.
Marketing in Canada is a marketing plan. Word of mouth solidifies legitimacy.
The higher MYDX goes green, the higher the lows for shorters being that they can only legally lower the sp 10%
It's already common knowledge to the public that most of CannaDX sales were due to word of mouth, which, though it is effecfive, it is not the fastest way to boost sales. MYDX marketing in Canada is getting the word out about the product and word of mouth will let those considering to buy, which is increasing daily, know that the product worked for them and why it's a valuable product to own.
It's a simple equation but with complex factors. The product is of value to those who buy it. Who wants to smoke something that decked him with nausea previously? MYDX's CannaDX is the only practical and affordable device that prevents this from happening to the consumer.
Yes, agreed all the way, longs know the market dips, sure it dipped much lower than expected (congratulations) but the ROI is never doubted and that's all that matters to investors.
Institutional financiers ONLY have their clients interests in mind, NOT the interests of the company or shareholders they buy shares into and from respectively. Many companies threatened by MYDX's success would need to go through these types of services to remain anonymous.
That's because we investors know how to invest and what companies to invest in. It's rare to find a company like MYDX in the OTC but we have done it and MYDX is NASDAQ bound!! NO investors are selling in 2017!!
Either way, it's insignificant as far as its effect on the current sp, that was never relevant. However, it's easy to claim that is the case. What's important is MYDX is getting funding for a product that is of high value to the public whether the public knows where the funding is coming from or not.
The way I see it, anyone who buys shares and sells at a loss is a toxic debt holder and it's not only being done by institutional financiers.
NO LOSS FOR INVESTORS HOLDING. Investors who sold, sold at a gain! Great investment eh?
Investors are intelligent which is why they invested in MYDX in the first place and are not selling in 2017. There is no realized loss as a MYDX investor. Looking forward to great ROI post 2017. Looking forward to the fireworks display when traders decide it's time to start moving up MYDX sp along with new multimillion dollar investors.
Traders will be doing all the work for us investors sitting back maxxin' relaxxin' and accumulating shares and watching the sp go into orbit with new investors finally realizing what MYDX is all about.
The joke is on whomever thinks MYDX investors are selling in 2017.
Millions of dollars of investment money bought shares through .022. I don't see millions of dollars selling shares. Why would an investor holding millions of shares sell each day at a lower price than the day before? Investors aren't selling in 2017 in the first place and investors, along with myself are holding the chips and will be the ones calling the shots as the price skyrockets!!
This looks like an institutional investor or at the very least, a company that institutions would trust to invest in indirectly supporting MYDX and remaining discreet:
http://newburghgazette.com/2017/06/18/intu-properties-lon-intu-analyst-target-prices/
Quote:
"INCORPORATED (OTCMKTS:MYDX) had an increase of 11.85% in short interest. 1607 Capital Prns Lc invested in 1.16% or 1.27M shares. Newburgh Gazette"
http://1607capital.com/wordpress/wp-content/uploads/2017/05/FirmOverview1Q17-B.pdf
Quote:
"1607 Capital Partners is an independently owned, boutique investment rm located in Richmond, Virginia. The rm specializes in investing across multiple asset classes using closed-end funds and other similarly discounted investment vehicles. The investment principals of the rm have, on average, nearly two decades of experience speci c to the closed-end fund universe. The rm manages assets primarily for institutional clients, as well as ultra high net worth individuals, through separately managed accounts and commingled limited partnerships."
https://fintel.io/so/us/mydx Another institutional investor reference.
It's the perfect cover, that's what everyone is more likely to believe.
What happens when someone buys 1million shares and sells them at a loss? It becomes much more than 1million shares at a much lower price and what happens after a couple of months of this process? Forced dilution. Who would like to see the pps spiral downward? I think we all know the answer to that. Competition feeling MYDX heat!!
That is FALSE. Millions of shares were bought AON as it peaked over .01. I don't see millions of shares being sold AON. I see 20k-100k shares for the most part sold at a time as well as bought. It's just been a bunch of forced dilution to get the pps down. Investors are continuing to accumulate. It's quite welcomed.
Investors aren't selling in 2017!
Investors who bought 100s of millions of shares in March are holding long and strong because it's an investment. That's what responsible investments are. All institutional investors know what to do. The pps is going to explode after Q2, that's why traders are also accumulating at these lows, not just investors. MYDX is about to rocket into orbit. NASDAQ BOUND!!